192 related articles for article (PubMed ID: 11349461)
1. Elevated leukaemia inhibitory factor (LIF) expression in lesional psoriatic skin: correlation with interleukin (IL)-8 expression.
Szepietowski J; Walker C; Hunter JA; McKenzie RC
J Dermatol; 2001 Mar; 28(3):115-22. PubMed ID: 11349461
[TBL] [Abstract][Full Text] [Related]
2. Leukaemia inhibitory factor and interleukin-8 expression in nonmelanoma skin cancers.
Szepietowski JC; Walker C; McKenna DB; Hunter JA; McKenzie RC
Clin Exp Dermatol; 2001 Jan; 26(1):72-8. PubMed ID: 11260184
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin.
Bonifati C; Mussi A; D'Auria L; Carducci M; Trento E; Cordiali-Fei P; Ameglio F
Arch Dermatol Res; 1998; 290(1-2):9-13. PubMed ID: 9522995
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
5. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin.
Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM
Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts.
Konstantinova NV; Duong DM; Remenyik E; Hazarika P; Chuang A; Duvic M
J Invest Dermatol; 1996 Oct; 107(4):615-21. PubMed ID: 8823370
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.
Ogilvie AL; Lüftl M; Antoni C; Schuler G; Kalden JR; Lorenz HM
Int J Immunopathol Pharmacol; 2006; 19(2):271-8. PubMed ID: 16831294
[TBL] [Abstract][Full Text] [Related]
8. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
[TBL] [Abstract][Full Text] [Related]
9. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T
J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948
[TBL] [Abstract][Full Text] [Related]
11. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.
Uyemura K; Yamamura M; Fivenson DF; Modlin RL; Nickoloff BJ
J Invest Dermatol; 1993 Nov; 101(5):701-5. PubMed ID: 7693825
[TBL] [Abstract][Full Text] [Related]
12. [Intralesional and anatomopathologic features of psoriatic erythroderma].
Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
[TBL] [Abstract][Full Text] [Related]
13. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.
Alessandrini F; Stachowitz S; Ring J; Behrendt H
J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity.
Bonifati C; Mussi A; Carducci M; Pittarello A; D'Auria L; Venuti A; Bagnato A; Salani D; Fazio M; Ameglio F
Acta Derm Venereol; 1998 Jan; 78(1):22-6. PubMed ID: 9498021
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1: a key inflammatory mediator in psoriasis?
Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-12 is increased in psoriatic skin.
Yawalkar N; Karlen S; Hunger R; Brand CU; Braathen LR
J Invest Dermatol; 1998 Dec; 111(6):1053-7. PubMed ID: 9856816
[TBL] [Abstract][Full Text] [Related]
19. The expression of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in psoriasis skin.
Chen X; Tan Z; Yue Q; Liu H; Liu Z; Li J
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):750-2. PubMed ID: 17357509
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
Chen SC; de Groot M; Kinsley D; Laverty M; McClanahan T; Arreaza M; Gustafson EL; Teunissen MB; de Rie MA; Fine JS; Kraan M
Arch Dermatol Res; 2010 Mar; 302(2):113-23. PubMed ID: 19517126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
